Current Time Inside Cache Tag Helper: 10/16/2021 11:12:13 PM and Model.SegmentId = 255

340B Management Systems  

Subject Expert
Jackson Tate
Research Director
KLAS Research Director - Jackson Tate

340B Management Systems (3 or More Covered Entities)

340B Management Systems (Less Than 3 Covered Entities)

Featured Report
340B 2020: An Update on the Evolving Market and a First Look at Contract Pharmacy Performance
340B 2020:
An Update on the Evolving Market and a First Look at Contract Pharmacy Performance
November 2020
View Report
View Related

Preferences

   Bookmark

Related Blogs

Decision Insights: 340B

Medication Inventory Management

ERP Decision Insights: A Volatile Market

The 3 Biggest Buying Decision Mistakes

Decision Insights: How the C-Suite Makes Buying Decisions




Current Time Inside Cache Tag Helper: 10/16/2021 4:06:42 PM and Model.SegmentId = 255
Related Reports View All Reports
Best in KLAS
KLAS article icon
2021 Best in KLAS Awards - Software and Professional Services
02 February 21    |   Mark Allphin and Sam Eaquinto
The Best in KLAS report recognizes software and services companies who excel in helping healthcare professionals improve patient care. All rankings are a direct result of the feedback of thousands of providers over the last year. A Best in KLAS award signifies to the healthcare IT industry the commitment and partnership that the top vendors should provide. Read the report to see the top-rated medical software and services for 2021. Watch sessions from our first-ever virtual Best In KLAS Award Show to hear from the winning vendors in each segment. View Awards Show Recordings
Decision Insights
KLAS article icon
340B Decision Insights 2020
22 January 20    |   Jackson Tate and Sam Eaquinto
The 340B program is considered a critical savings opportunity for covered entities and their contracted pharmacies, and over the past couple of years, KLAS has noted an increase in provider organization purchase decisions in the third-party administrator space. Some organizations are putting out RFPs because their current contracts are ending, but many others are seeking out solutions to fill the functionality and service gaps of their current 340B vendor. Newer market entrants, such as PSG and RxStrategies, represent additional options to consider alongside the already-established market players. While organizations continue to look for new technology and functionality in potential vendor partners, factors like service, support, and relationships have proven to be key to long-term customer success.
Performance
KLAS article icon
Medication Inventory Management 2019
13 August 19    |   Jackson Tate and Paul Warburton
Enterprise medication inventory management (MIM) can create substantial efficiency gains and financial savings, but the reality today is that no pharmacy or EMR vendor delivers the full visibility hospitals need. Even those vendors furthest down the path lag behind the inventory capabilities found in other industries, such as retail and manufacturing. To highlight which vendors have made progress and where gaps still remain, this report compares the reality of each vendor’s MIM offering with the full spectrum of capabilities required for true enterprise MIM. Additional findings are also highlighted in two areas that impact MIM—automated dispensing cabinets and medication kit/tray management solutions.



Exceptions

R
Regional Classification
C
Component Products
S
Superseded Products
NP
Not Primary Products
DR
Data Review
MS
Limited Market Share
E
Emerging Technology
FR
Data frozen, live data no longer collected.

The following exceptions refer to the number of unique organizations contributing evaluations to the overall score (minimum of 15 required).

340B Management Systems

# of Unique Organization Evaluations:

0 - 5
L
6 - 14

Reducing Filters

Unlike sizing filters, reducing filters DO NOT recalculate scores based on the evaluations that meet these requirements. They narrow the list of solutions to show the vendors and solutions that can meet a specific need.

This data is based on interviews with a sample of the firms' recent clients. As a result, it is not necessarily comprehensive of all work a firm may do in this segment.

We require a minimum of 2 confirmations of a service performed in the last 3 years for a solution to qualify.

Market Energy

This is an indication of the relative considerations of Market Energy within the shown products from the

Decision Insights KLAS Data

Market Energy Levels:

Low Market Energy
Medium Market Energy
High Market Energy
Not Enough Data
We use cookies! We use essential and basic aggregated, depersonalized Google Analytics cookies to provide the type of content which our visitors are most interested in.  Cookie Policy    
​